Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

Finally, there are potential issues to be aware of that can lead to adverse outcomes, including: The manufacturer of Ozempic recently released a statement containing tips on protecting against ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

As trendy weight loss drugs change eating habits, food manufacturers are trying their best to cash in. Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change ...

Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Anyone interested in taking Ozempic should consult a doctor before use. Furthermore, its manufacturer advises those who experience inflammation of the pancreas (pancreatitis) or changes in vision ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take ...

Ozempic and Wegovy, in particular ... the president and CEO of Pharmaceutical Research and Manufacturers of America, said in a statement. Late last year, the Centers for Medicare & Medicaid ...